Comparison of Stromal Vascular Fraction and Adipose-Derived Stem Cells for Protection of Renal Function in a Rodent Model of Ischemic Acute Kidney Injury
Open Access
- 6 May 2022
- journal article
- research article
- Published by Wiley in Stem Cells International
- Vol. 2022, 1-16
Abstract
Aims. Few studies have compared the use of different cell types derived from adipose tissue or the optimal route for efficient and safe cell delivery in ischemic acute kidney injury (AKI). We compared the abilities of stromal vascular fraction (SVF) and adipose-derived stem cells (ADSC), injected via three different routes, to protect renal function in a rodent model of ischemic AKI. Methods. Ninety male Sprague-Dawley rats were randomly divided into 9 groups: sham, nephrectomy control, AKI control, transaortic renal arterial SVF injection, renal parenchymal SVF injection, tail venous SVF injection, transaortic renal arterial ADSC injection, renal parenchymal ADSC injection, and tail venous ADSC injection groups. Their renal function was assessed 4 days before and 1, 2, 3, 4, 7, and 14 days after surgical procedures to induce ischemic AKI. The histomorphometric studies were performed 14 days after surgical procedures. Results. Renal parenchymal injection of SVF notably reduced the level of serum blood urea nitrogen and creatinine elevation compared to the AKI control group. Renal parenchymal injection of SVF notably reduced the level of creatinine clearance decrease. In addition, collagen content was lower in the renal parenchymal SVF injection group, and fibrosis was reduced. Apoptosis was reduced in the renal parenchymal SVF injection group, and proliferation was increased. The expression levels of antioxidative markers such as glutathione reductase and peroxidase were higher in the renal parenchymal SVF injection group. Conclusions. Our findings suggest that renal function is protected from ischemic AKI through renal parenchymal injection of SVF, which has enhanced antifibrotic, antiapoptotic, and antioxidative effects.Keywords
Funding Information
- Asan Institute for Life Sciences, Asan Medical Center (2017-576, 2015R1C1A1A01054399)
- Ministry of Science, ICT and Future Planning (2017-576, 2015R1C1A1A01054399)
- National Research Foundation of Korea (2017-576, 2015R1C1A1A01054399)
This publication has 37 references indexed in Scilit:
- Adipose-Derived Mesenchymal Stem Cell Protects Kidneys against Ischemia-Reperfusion Injury through Suppressing Oxidative Stress and Inflammatory ReactionJournal of Translational Medicine, 2011
- Fresh and cryopreserved, uncultured adipose tissue-derived stem and regenerative cells ameliorate ischemia–reperfusion-induced acute kidney injuryNephrology Dialysis Transplantation, 2010
- Not a Process of Simple Vicariousness, the Differentiation of Human Adipose-Derived Mesenchymal Stem Cells to Renal Tubular Epithelial Cells Plays an Important Role in Acute Kidney Injury RepairingStem Cells and Development, 2010
- Mobilized Human Hematopoietic Stem/Progenitor Cells Promote Kidney Repair After Ischemia/Reperfusion InjuryCirculation, 2010
- Pulmonary Passage is a Major Obstacle for Intravenous Stem Cell Delivery: The Pulmonary First-Pass EffectStem Cells and Development, 2009
- Identification of an aberrant cell line among human adipose tissue-derived stem cell isolatesDifferentiation, 2009
- The Immunogenicity of Human Adipose‐Derived Cells: Temporal Changes In VitroStem Cells, 2006
- Transplantation of Human Hematopoietic Stem Cells into Ischemic and Growing Kidneys Suggests a Role in Vasculogenesis but Not TubulogenesisStem Cells, 2006
- Differential Gender Differences in Ischemic and Nephrotoxic Acute Renal FailureAmerican Journal of Nephrology, 2005
- Immunomodulatory effect of human adipose tissue‐derived adult stem cells: comparison with bone marrow mesenchymal stem cellsBritish Journal of Haematology, 2005